Company News
Sai Parenteral's Board Meeting for Australian Investment
Sai Parenteral's intimates exchanges of its April 20, 2026 board meeting under SEBI LODR Regulation 29(1)(d).
Board to consider investing in/lending to Australian step-down subsidiary Noumed Pharmaceu
